420 related articles for article (PubMed ID: 6375065)
1. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Nakada T
Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
[TBL] [Abstract][Full Text] [Related]
2. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
Magill SB; Raff H; Shaker JL; Brickner RC; Knechtges TE; Kehoe ME; Findling JW
J Clin Endocrinol Metab; 2001 Mar; 86(3):1066-71. PubMed ID: 11238487
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of kallikrein before and after operation for aldosterone-producing adenoma.
Hesse B; Rasmussen S; Lund JO; Christensen P; Damkjaer Nielsen M
Acta Med Scand; 1985; 217(5):501-5. PubMed ID: 3895826
[TBL] [Abstract][Full Text] [Related]
4. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
Griffing GT; Dale SL; Holbrook MM; Melby JC
J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
[TBL] [Abstract][Full Text] [Related]
5. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Irony I; Kater CE; Biglieri EG; Shackleton CH
Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
[TBL] [Abstract][Full Text] [Related]
6. The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.
Nakada T; Furuta H; Katayama T; Sumiya H; Shimazaki J
J Urol; 1989 Jul; 142(1):13-8. PubMed ID: 2525199
[TBL] [Abstract][Full Text] [Related]
7. [Primary hyperaldosteronism: differentiation between aldosterone-producing adenoma and idiopathic adrenocortical hyperplasia (author's transl)].
Wambach G; Helber A; Bönner G; Hummerich W; Konrads A; Meurer KA
Dtsch Med Wochenschr; 1982 Jun; 107(24):923-7. PubMed ID: 7084059
[TBL] [Abstract][Full Text] [Related]
8. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic results of primary aldosteronism with special reference to renal or renovascular lesions.
Nakada T; Koike H; Akiya T; Katayama T; Takata M; Iida H; Mizumura Y
Int Urol Nephrol; 1988; 20(1):67-76. PubMed ID: 3283072
[TBL] [Abstract][Full Text] [Related]
10. Identification and differentiation of surgically correctable hypertension due to primary aldosteronism.
Herf SM; Teates DC; Tegtmeyer CJ; Vaughan ED; Ayers CR; Carey RM
Am J Med; 1979 Sep; 67(3):397-402. PubMed ID: 474585
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Newton MA; Laragh JH
J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
[No Abstract] [Full Text] [Related]
12. 21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism.
Abdelhamid S; Lewicka S; Vecsei P; Winter J
Cardiology; 1985; 72 Suppl 1():102-6. PubMed ID: 4053120
[TBL] [Abstract][Full Text] [Related]
13. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Newton MA; Laragh JH
J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
[No Abstract] [Full Text] [Related]
14. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
Holland OB; Chud JM; Braunstein H
J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
[TBL] [Abstract][Full Text] [Related]
15. Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism.
Seino M; Abe K; Sakurai Y; Irokawa N; Yasujima M; Chiba S; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1977 Feb; 121(2):111-9. PubMed ID: 847738
[TBL] [Abstract][Full Text] [Related]
16. Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
Lund JO; Nielsen MD
Acta Endocrinol (Copenh); 1980 Jan; 93(1):100-7. PubMed ID: 6986736
[TBL] [Abstract][Full Text] [Related]
17. Primary aldosteronism: diagnosis and noninvasive lateralization procedures.
Vetter H; Fischer M; Galanski M; Stieber U; Tenschert W; Baumgart P; Winterberg B; Vetter W
Cardiology; 1985; 72 Suppl 1():57-63. PubMed ID: 3902232
[TBL] [Abstract][Full Text] [Related]
18. Urinary kallikrein in normal renin essential hypertension.
Lawton WJ; Fitz AE
Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
[TBL] [Abstract][Full Text] [Related]
19. Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism.
Miyamori I; Takeda Y; Takasaki H; Itoh Y; Iki K; Takeda R
J Endocrinol Invest; 1992 Jan; 15(1):19-24. PubMed ID: 1560187
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.
Hennings J; Andreasson S; Botling J; Hägg A; Sundin A; Hellman P
Langenbecks Arch Surg; 2010 Feb; 395(2):133-7. PubMed ID: 19418066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
